Vitamin D receptor activation influences the ERK pathway and protects against neurological deficits and neuronal death

Jie Yuan, Xin Guo, Zhengang Liu, Xiuqin Zhao, Yan Feng, Sixin Song, Changmeng Cui, Pei JiangInternational Journal of Molecular Medicine 2017 · DOI

Abstract

Global cerebral ischemia (GCI) is a devastating condition characterized by neurological deficits and delayed neuronal apoptosis. This study investigates the neuroprotective effects of calcitriol, the active metabolite of Vitamin D, in a rat model of GCI. By activating the nuclear Vitamin D receptor (VDR) and the downstream ERK1/2 signaling pathway, calcitriol treatment was found to attenuate brain edema, reduce infarct volume, and improve functional recovery. These findings suggest that calcitriol-mediated VDR activation represents a potential therapeutic strategy for acute brain injury.

Introduction

Global cerebral ischemia (GCI), often resulting from cardiac arrest, triggers a cascade of brain damage. While immediate oxygen deprivation causes primary injury, a secondary phase of delayed neuronal death occurs in the days following the event, particularly in the cerebral cortex. Current clinical interventions to mitigate this secondary damage are limited. Calcitriol, known for its role in calcium homeostasis, also acts as a neuroprotective hormone through the Vitamin D receptor (VDR) expressed in the brain. This study explores whether post-ischemic administration of calcitriol can interrupt the apoptotic cascade and preserve neurological function.

Methodology

The study utilized a rat model of GCI induced by bilateral carotid artery ligation and hypotension. A total of 145 male Sprague Dawley rats were assigned to groups including Sham, GCI-only, and GCI treated with calcitriol (1 µg/kg). Researchers evaluated outcomes through neurological severity scores (NSS), brain water content, and 2,3,5-triphenyltetrazolium chloride (TTC) staining to measure infarct volume. Cellular and molecular changes were analyzed using Hematoxylin and Eosin (H&E) staining, Transmission Electron Microscopy (TEM), Western blotting, and immunofluorescence. To confirm the mechanism, the ERK1/2 inhibitor PD98059 was employed.

Results and Discussion

Reduction in Brain Tissue Damage

One of the most striking findings was the significant reduction in infarcted brain tissue following calcitriol treatment. TTC staining revealed that while GCI caused extensive tissue death, calcitriol administration significantly lowered the infarction ratio (P<0.005).

Figure 1: TTC staining of brain sections (A) and quantification of the infarction ratio (B) showing significant reduction in tissue death with calcitriol treatment.

Cellular and Structural Preservation

Histopathological analysis via H&E staining showed that calcitriol treatment prevented the typical signs of neuronal damage seen after GCI, such as cell shrinkage and nuclear pyknosis. Furthermore, TEM imaging demonstrated that calcitriol preserved the ultrastructure of neurons, maintaining the integrity of nuclear membranes and mitochondria, which otherwise showed significant vacuolation and chromatin condensation in untreated GCI rats.

Figure 2: H&E staining (A) and TEM images (B) illustrating the preservation of neuronal morphology and ultrastructure in the calcitriol-treated group compared to the GCI group.

Functional Recovery and Molecular Mechanism

Functional assessments showed that calcitriol-treated rats had significantly lower neurological deficit scores starting from day 3 post-injury. Molecular analysis revealed that this protection is mediated by the VDR-ERK1/2 pathway. Calcitriol treatment increased VDR expression and ERK1/2 phosphorylation, which subsequently shifted the balance of apoptotic proteins: decreasing the "executioner" cleaved Caspase-3 and increasing the "survival" protein Bcl-2. The use of an ERK1/2 inhibitor (PD98059) effectively abolished these protective effects, confirming the pathway's essential role.

Conclusion

This study provides strong evidence that calcitriol exerts neuroprotective effects against GCI-induced damage. By activating the VDR and the ERK1/2 signaling pathway, calcitriol reduces brain edema, preserves neuronal structure, and improves functional outcomes. These results highlight Vitamin D receptor activation as a promising target for therapeutic intervention in ischemic brain injury.

Summary updated

Abstract

Previous studies have demonstrated that global cerebral ischemia (GCI) causes neurological deficits and neuronal cell apoptosis. Calcitriol, a biologically active metabolite of vitamin D, exerts its endocrinological influence via nuclear vitamin D receptor. It is being assessed as an emerging therapeutic strategy in models of various medical conditions, including acute brain injury. The purpose of the present study was to investigate the neuroprotective effects of calcitriol on GCI and further refine the potential underlying mechanisms. A total of 145 male rats were assigned to 5 groups as follows: Sham group, GCI group, calcitriol treatment group, PD98059 treatment group and vehicle-treated group. Brain water content and neurologic severity score were assessed to evaluate the brain edema and neurological deficits of rats. Histopathological changes and ultrastructures of cells were observed via hematoxylin and eosin stain and transmission electron microscopy, respectively. Immunofluorescent staining and western blot analysis were used to assess the expression of proteins and their co-localization at the molecular level. The results demonstrated that post-GCI administration of calcitriol attenuated brain edema and improved neurological function in rats. Calcitriol also caused marked extracellular signal-regulated kinase 1/2 pathway activation, and thereby attenuated neuronal apoptosis. The present study provided novel clues for understanding the mechanisms by which calcitriol exerts its neuroprotective activity in a rat model of GCI.
BibTeX
@article{yuan2017vitamin,
  author = {Jie Yuan and Xin Guo and Zhengang Liu and Xiuqin Zhao and Yan Feng and Sixin Song and Changmeng Cui and Pei Jiang},
  title = {{Vitamin D receptor activation influences the ERK pathway and protects against neurological deficits and neuronal death}},
  journal = {International Journal of Molecular Medicine},
  year = {2017},
  doi = {10.3892/ijmm.2017.3249},
}
Figure